---
title: "300272.SZ (300272.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300272.SZ/news.md"
symbol: "300272.SZ"
name: "300272.SZ"
parent: "https://longbridge.com/en/quote/300272.SZ.md"
datetime: "2026-03-18T14:17:00.505Z"
locales:
  - [en](https://longbridge.com/en/quote/300272.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300272.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300272.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/300272.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/300272.SZ/news.md)


# 300272.SZ (300272.SZ) — Related News

### [Canature Health signs a research cooperation agreement to enhance core competitiveness in the field of cell research and application](https://longbridge.com/en/news/279238657.md)
*2026-03-16T09:49:53.000Z*
> On the evening of March 16th, Canature Health (300272) announced that in order to actively respond to the national polic

### [Canature Health's subsidiary signs a letter of intent for cooperation with Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital](https://longbridge.com/en/news/279223540.md)
*2026-03-16T08:05:05.000Z*
> Canature Health announced that its subsidiary Shanghai Yuantian Biotechnology Co., Ltd. has signed a letter of intent fo

### [Multiple listed companies respond to "universal miracle drug," with some products urgently removed from shelves](https://longbridge.com/en/news/279217108.md)
*2026-03-16T07:14:03.000Z*
> Multiple listed companies have responded to the exposure of the "universal miracle drug" exosome by CCTV's 3.15 Gala, wi

### [The A-share listed company Canature Health has a layout in exosome therapy, with business directions including pet health and anti-aging](https://longbridge.com/en/news/279160244.md)
*2026-03-15T14:10:08.000Z*
> A-share listed company Canature Health is laying out exosome therapy, with business directions including pet health and 

### [Promoting the dual main business strategy layout, Canature Health elaborates on the acquisition process of YuanNeng Group's assets](https://longbridge.com/en/news/269215306.md)
*2025-12-10T10:28:18.000Z*
> Canature Health is accelerating the pace of its dual main business strategy. Recently, the company's chairman, Qu Jiangu

### [Canature Health's 7 years and 4 rounds of maneuvering, cross-industry gamble on cell "Bermuda" doubts difficult to dispel](https://longbridge.com/en/news/267353983.md)
*2025-11-25T12:31:22.000Z*
> Canature Health, against the backdrop of a wave of withdrawals in the cell therapy industry, acquired the loss-making ce

### [Limit Up Review: Cell Immunotherapy Concept Strengthens, Oil and Photovoltaic Concepts Active](https://longbridge.com/en/news/265487963.md)
*2025-11-12T10:11:01.000Z*
> As of the close, the Shanghai Composite Index fell 0.07%, the Shenzhen Component Index fell 0.36%, and the ChiNext Index

### [Dragon and Tiger List | Zuo Shou Xin Yi and quantitative funds appear on the first board of Canature Health, with the former purchasing 20.4329 million yuan](https://longbridge.com/en/news/265487062.md)
*2025-11-12T10:02:13.000Z*
> On November 12th, Canature Health (300272) hit the daily limit, reaching 8.48 yuan, an increase of 19.94%. According to